These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10389970)

  • 1. Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome.
    Burt EC; McGown G; Thorncroft M; James LA; Birch JM; Varley JM
    Br J Cancer; 1999 Apr; 80(1-2):9-10. PubMed ID: 10389970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
    Malmer B; Grönberg H; Andersson U; Jonsson BA; Henriksson R
    Acta Oncol; 2001; 40(5):633-7. PubMed ID: 11669337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel PTEN intronic deletion in Li-Fraumeni syndrome and its effect on RNA processing.
    Brown LT; Sexsmith E; Malkin D
    Cancer Genet Cytogenet; 2000 Nov; 123(1):65-8. PubMed ID: 11120338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
    Zhou XP; Sanson M; Hoang-Xuan K; Robin E; Taillandier L; He J; Mokhtari K; Cornu P; Delattre JY; Thomas G; Hamelin R
    Ann Neurol; 1999 Dec; 46(6):913-6. PubMed ID: 10589545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
    MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK
    J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Bougeard G; Limacher JM; Martin C; Charbonnier F; Killian A; Delattre O; Longy M; Jonveaux P; Fricker JP; Stoppa-Lyonnet D; Flaman JM; Frébourg T
    J Med Genet; 2001 Apr; 38(4):253-7. PubMed ID: 11370630
    [No Abstract]   [Full Text] [Related]  

  • 7. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer.
    Shugart YY; Cour C; Renard H; Lenoir G; Goldgar D; Teare D; Easton D; Rahman N; Gusterton R; Seal S; Barfoot R; Stratton M; Mangion J; Peelen T; van den Ouweland A; Meijers H; Devilee P; Eccles D; Lynch H; Weber B; Stoppa-Lyonnet D; Bignon YJ; Chang-Claude J
    J Med Genet; 1999 Sep; 36(9):720-1. PubMed ID: 10507734
    [No Abstract]   [Full Text] [Related]  

  • 9. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
    Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
    Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
    Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
    Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
    Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
    J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method to distinguish between the MMAC1/PTEN gene and its pseudogene in RT-PCR analysis of point mutations.
    Liu J; Kagan J
    Biotechniques; 1999 Jan; 26(1):19-22, 24. PubMed ID: 9894586
    [No Abstract]   [Full Text] [Related]  

  • 15. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
    Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
    Soussi T; Leblanc T; Baruchel A; Schaison G
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.
    Ishii N; Maier D; Merlo A; Tada M; Sawamura Y; Diserens AC; Van Meir EG
    Brain Pathol; 1999 Jul; 9(3):469-79. PubMed ID: 10416987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.